Pfizer Inc
The pet drugs vets are now prescribing look a lot more like human medications
If you want to understand how different the human and animal medicine and vaccine industries have historically been, you don’t need to look much further than weight loss drugs. On the human side, Novo Nordisk and Eli Lilly struggled to meet the demand for Ozempic, Wegovy, Mounjaro and Zepbound, respectively, since introducing them, as the […]
Read More
Viking stock doubled Tuesday. In this article's the place the following moves in the weight problems room could arrive from
Anti-weight problems drugmakers Novo Nordisk and Eli Lilly have a big lead on their competitiveness, but supplied the large and beneficial marketplace, rivals are nevertheless keen to sign up for the race. Bank of America analyst Geoff Meacham has been quite bullish about the option, which he phone calls “unparalleled” offered the prevalence of obesity […]
Read More
Viking Therapeutics stock jumps 80% after positive weight loss drug trial results
Cr | Istock | Getty Images Shares of Viking Therapeutics soared more than 80% in premarket trading Tuesday after the company’s experimental weight loss drug showed promising initial results in a mid-stage trial. Viking Therapeutics is one of several small obesity drugmakers hoping to enter the budding weight loss drug industry, which analysts say could […]
Read More
Historical past demonstrates the ideal trade has generally been to obtain the inventory getting kicked out of the Dow Industrials
If historical past is any tutorial, Walgreens Boots Alliance could fare better right after receiving tossed from the Dow Jones Industrial Typical . Amazon changed Walgreens on Monday, marking the initially modify in the index considering that 2020. It will come a lot less than six many years right after the U.S. and British pharmacy […]
Read More
These selection plays can hedge against a reversal in stock market momentum, Goldman says
The current market rally found its footing after again following Nvidia ‘s earnings report this week, but buyers may well still want to put together for a reversal, in accordance to Goldman Sachs. John Marshall of Goldman’s derivatives study staff explained in a Feb. 22 observe that investors can use choices to place for a […]
Read More
Here's why we would be considering buying more Eli Lilly shares if they were down Tuesday
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. 1. U.S. stocks tumbled Tuesday on hotter-than-expected retail inflation data. The surprise uptick in the January consumer price index sent bond yields higher and the Dow , the S & […]
Read More
Federal judge tosses lobbying group's lawsuit challenging Medicare drug price negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS) building on October 06, 2022 in Washington, DC. Anna Moneymaker | Getty Images A federal judge on Monday tossed a lawsuit brought by a major pharmaceutical industry lobbying group and two other organizations, which challenged […]
Read More
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The insatiable demand for weight loss drugs is trouncing supply, leaving many patients struggling to find the injectable treatments. The dominant weight loss drugmakers, Novo Nordisk and Eli Lilly, have said […]
Read More
Tech execs are telling traders they have to commit revenue to make dollars on AI
Google CEO Sundar Pichai, arrives for a US Senate bipartisan Synthetic Intelligence (AI) Insight Discussion board at the US Capitol in Washington, DC, on September 13, 2023. Mandel Ngan | AFP | Getty Photos It was a massive week for tech earnings, with Microsoft, Meta, Alphabet, Amazon and Apple all reporting around the past couple days. Artificial […]
Read More
Bristol Myers Squibb results top estimates as new drugs post strong sales growth
Bristol Myers Squibb reported quarterly earnings and revenue that topped expectations on Friday as its portfolio of new drugs posted strong sales growth. Here’s what the company reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG, formerly known as Refinitiv: Earnings per share: $1.70 […]
Read More